Cite
Novel tumour-infiltrating lymphocyte-related risk stratification based by flow cytometry for patients with de novo angioimmunoblastic T cell lymphoma.
MLA
Zhu, Qiqi, et al. “Novel Tumour-Infiltrating Lymphocyte-Related Risk Stratification Based by Flow Cytometry for Patients with de Novo Angioimmunoblastic T Cell Lymphoma.” Annals of Hematology, vol. 100, no. 3, Mar. 2021, pp. 715–23. EBSCOhost, https://doi.org/10.1007/s00277-020-04389-5.
APA
Zhu, Q., Deng, X., Yao, W., Chen, Z., Ye, Y., Gao, L., Zhang, W., Liu, W., & Zhao, S. (2021). Novel tumour-infiltrating lymphocyte-related risk stratification based by flow cytometry for patients with de novo angioimmunoblastic T cell lymphoma. Annals of Hematology, 100(3), 715–723. https://doi.org/10.1007/s00277-020-04389-5
Chicago
Zhu, Qiqi, Xueqin Deng, Wenqing Yao, Zihang Chen, Yunxia Ye, Limin Gao, Wenyan Zhang, Weiping Liu, and Sha Zhao. 2021. “Novel Tumour-Infiltrating Lymphocyte-Related Risk Stratification Based by Flow Cytometry for Patients with de Novo Angioimmunoblastic T Cell Lymphoma.” Annals of Hematology 100 (3): 715–23. doi:10.1007/s00277-020-04389-5.